Owner Pfizer Inc.

Inventors Rogers, Michael David; Schmidt, Michelle Ann; McReynolds, Matthew David; Roark, William Howard; Scholten, Jeffrey Allen; Hamper, Bruce Cameron; McDonald, Joseph J.; Massa, Mark Alan; Strohback, Joseph Walter; Grapperhaus, Margaret L.; Fletcher, Theresa R.; Morris, Mark Anthony; Schnute, Mark E.; Carroll, Jeffery Neal; Hanau, Cathleen Elizabeth; Nahra, Joe; Ruminski, Peter G.; O'Brien, Patrick Michael

Agent Spruson & Ferguson

Pub. Number AU-A-2008281509

PCT Pub. Number WO2009/016498

Priority 60/953,604 02.08.07 US; 61/015,533 20.12.07 US

Filing date 29 July 2008

Wipo publication date 5 February 2009

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms